. Author manuscript; available in PMC: 2013 Apr 1.

Published in final edited form as: Breast Cancer Res Treat. 2011 Dec 27;132(3):1063–1072. doi: 10.1007/s10549-011-1928-x

Table 1.

Patient Characteristics

Baseline characteristics		N=54 (%)

Age
Median Range		54 27–77

Ethnicity/Race
Hispanic White Black Asian Unknown		8 (15%) 37 (69%) 11 (20%) 2 (4%) 4 (7%)

Hormone receptor status
ER+/PR+ ER+/PR− ER−/PR−		26 (48%) 12 (22%) 16 (30%)

ECOG performance status
0 1 2 Unk		34 (63%) 18 (33%) 1 (2%) 1 (2%)

Disease- free interval
0–12 months >12 months		19 (35%) 35 (65%)

No. of metastatic sites
1 2 ? 3		14 (26%) 22 (41%) 18 (33%)

Metastatic sites
Lung Liver Non-visceral only		18 (33%) 24 (44%) 21 (39%)

Prior adjuvant taxane chemotherapy		16 (29%)